{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:05:26Z","timestamp":1790330726779,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.mehy.2012.03.021","type":"journal-article","created":{"date-parts":[[2012,4,30]],"date-time":"2012-04-30T12:41:15Z","timestamp":1335789675000},"page":"8-12","source":"Crossref","is-referenced-by-count":37,"title":["N-acetyl-cysteine in the treatment of Parkinson\u2019s disease. What are we waiting for?"],"prefix":"10.1016","volume":"79","author":[{"given":"Marcos Arturo","family":"Mart\u00ednez-Banaclocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2012.03.021_b0005","first-page":"148","article-title":"Are dopaminergic neurons selectively vulnerable to Parkinson\u2019s disease?","volume":"60","author":"Agid","year":"1993","journal-title":"Adv Neurol"},{"key":"10.1016\/j.mehy.2012.03.021_b0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0303-8467(98)00009-2","article-title":"Genetic and environmental risk factors in Parkinson\u2019s Disease","volume":"100","author":"Veldman","year":"1998","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.mehy.2012.03.021_b0015","first-page":"215","article-title":"Idiopathic Parkinson\u2019s disease: a genetic and environmental model","volume":"80","author":"Williams","year":"1999","journal-title":"Adv Neurol"},{"key":"10.1016\/j.mehy.2012.03.021_b0020","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/j.1471-4159.1993.tb13430.x","article-title":"Age-dependent impairment of mitochondrial function in primate brain","volume":"60","author":"Bowling","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2012.03.021_b0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0047-6374(90)90024-A","article-title":"Age-related modification of cytochrome c oxidase activity in discrete brain regions","volume":"55","author":"Curti","year":"1990","journal-title":"Ageing Dev"},{"key":"10.1016\/j.mehy.2012.03.021_b0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0006-8993(94)91699-3","article-title":"Impairment of mitochondrial oxidative phosphorylation in the brain of aged mice","volume":"644","author":"Ferr\u00e1ndiz","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2012.03.021_b0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3940(94)90254-2","article-title":"Age-related changes in glutathione and lipid peroxide content in mouse synaptic mitochondria: relationship to cytochrome c oxidase decline","volume":"170","author":"Mart\u00ednez-Banaclocha","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2012.03.021_b0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0047-6374(95)01644-F","article-title":"Depletion of cytosolic GSH decreases the ATP levels and viability of synaptosomes from aged mice but not from young mice","volume":"84","author":"Mart\u00ednez-Banaclocha","year":"1995","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.mehy.2012.03.021_b0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0006-8993(99)02349-5","article-title":"N-acetylcysteine delays age-associated memory impairment in mice. role in synaptic mitochondria","volume":"855","author":"Mart\u00ednez-Banaclocha","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2012.03.021_b0050","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0006-8993(96)00708-1","article-title":"Age-related increase in oxidized proteins in mouse synaptic mitochondria","volume":"731","author":"Mart\u00ednez-Banaclocha","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2012.03.021_b0055","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.mehy.2012.03.021_b0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0378-4274(89)90168-9","article-title":"Biochemical mechanism of action of the dopaminergic neurotoxin MPTP","volume":"48","author":"Sayre","year":"1989","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.mehy.2012.03.021_b0065","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2012.03.021_b0070","first-page":"265","article-title":"Role of mitochondria in the etiology and pathogenesis of Parkinson\u2019s disease","volume":"1271","author":"Mizuno","year":"1995","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.mehy.2012.03.021_b0075","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ana.410400417","article-title":"Origin and functional consequences of the complex I defect in Parkinson\u2019s disease","volume":"40","author":"Swerdlow","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2012.03.021_b0080","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/j.1471-4159.1990.tb05809.x","article-title":"Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson\u2019s disease","volume":"55","author":"Schapira","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2012.03.021_b0085","first-page":"415","article-title":"A common LRRK2 mutation in idiopathic Parkinson\u2019s disease","volume":"365","author":"Gilks","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2012.03.021_b0090","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0304-3940(82)90390-1","article-title":"Parkinson\u2019s disease: a disorder due to nigral glutathione deficiency?","volume":"33","author":"Perry","year":"1982","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2012.03.021_b0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0304-3940(86)90320-4","article-title":"Idiopathic Parkinson\u2019s disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients","volume":"67","author":"Perry","year":"1986","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2012.03.021_b0100","doi-asserted-by":"crossref","first-page":"17205","DOI":"10.1016\/S0021-9258(19)77815-6","article-title":"Glutathione metabolism and its selective modification","volume":"263","author":"Meister","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2012.03.021_b0105","first-page":"24","article-title":"Oxidative mechanisms in nigral cell death in Parkinson\u2019s disease","volume":"13","author":"Jenner","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.mehy.2012.03.021_b0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0925-4439(97)00070-7","article-title":"Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson\u2019s disease","volume":"1362","author":"Cassarino","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.mehy.2012.03.021_b0115","doi-asserted-by":"crossref","unstructured":"Jenner P. Oxidative stress in Parkinson\u2019s disease. Ann Neurol 2003;53:S26\u201336 [discussion S36\u201338].","DOI":"10.1002\/ana.10483"},{"key":"10.1016\/j.mehy.2012.03.021_b0120","doi-asserted-by":"crossref","first-page":"7631","DOI":"10.1073\/pnas.95.13.7631","article-title":"Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione","volume":"95","author":"Clementi","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2012.03.021_b0125","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1471-4159.2004.02929.x","article-title":"Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson\u2019s disease","volume":"92","author":"Hsu","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2012.03.021_b0130","doi-asserted-by":"crossref","first-page":"26096","DOI":"10.1074\/jbc.M000120200","article-title":"Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson\u2019s disease","volume":"275","author":"Jha","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2012.03.021_b0135","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","article-title":"Kinetic stabilization of the alpha -Synuclein proto-fibril by a dopamine- alpha -synuclein adducts","volume":"294","author":"Conway","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.mehy.2012.03.021_b0140","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective alpha- synuclein nitration in synucleinopathy lesions","volume":"290","author":"Giasson","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.mehy.2012.03.021_b0145","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1212\/WNL.50.3.793","article-title":"Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in parkinsonian patients","volume":"50","author":"Shults","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2012.03.021_b0150","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1056\/NEJM199301213280305","article-title":"Effects of tocopherol and deprenyl on the progression of disability in early Parkinson\u2019s disease","volume":"328","year":"1993","journal-title":"New Engl J Med"},{"key":"10.1016\/j.mehy.2012.03.021_b0155","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1474-4422(05)70097-1","article-title":"Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson\u2018s disease: a meta-analysis","volume":"4","author":"Etminan","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.mehy.2012.03.021_b0160","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0278-5846(96)00103-0","article-title":"Reduced intravenous glutathione in the treatment of early Parkinson\u2019s disease","volume":"20","author":"Sechi","year":"1996","journal-title":"Progr Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.mehy.2012.03.021_b0165","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1523\/JNEUROSCI.21-10-03322.2001","article-title":"Pyruvate released by astrocytes protects neurons from copper-catalyzed cysteine neurotoxicity","volume":"21","author":"Wang","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2012.03.021_b0170","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0006-8993(00)02005-9","article-title":"N-acetylcysteine elicited increase in complex I activity in synaptic mitochondria from aged mice. Implications for treatment of Parkinson\u2019s disease","volume":"859","author":"Mart\u00ednez-Banaclocha","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2012.03.021_b0175","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1054\/mehy.2000.1194","article-title":"Therapeutic potential of N-acetyl-cysteine in age-related mitochondrial neurodegenerative diseases","volume":"56","author":"Mart\u00ednez-Banaclocha","year":"2001","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2012.03.021_b0180","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0006-8993(99)01819-3","article-title":"N-acetylcysteine elicited increase in cytochrome c oxidase activity in mice synaptic mitochondria","volume":"842","author":"Mart\u00ednez-Banaclocha","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2012.03.021_b0185","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0006-8993(97)00493-9","article-title":"N-acetylcysteine protects against age-related increase in oxidized proteins in mouse synaptic mitochondria","volume":"762","author":"Mart\u00ednez-Banaclocha","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2012.03.021_b0190","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Banaclocha M, Mart\u00ednez N, Hern\u00e1ndez, et al. Hypothesis: can N-acetylcysteine be beneficial in Parkinson\u2019s disease? Life Sci 1999;64:1253\u20137.","DOI":"10.1016\/S0024-3205(98)00472-X"},{"key":"10.1016\/j.mehy.2012.03.021_b0195","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1080\/107157602100006445","article-title":"Antioxidants inhibit the human cortical neuron apoptosis induced by hydrogen peroxide, tumor necrosis factor alpha, dopamine and beta-amyloid peptide 1\u201342","volume":"36","author":"Medina","year":"2002","journal-title":"Free Radic Res"},{"key":"10.1016\/j.mehy.2012.03.021_b0200","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0197-0186(99)00126-6","article-title":"In-vivo glutathione elevation protects against hydroxyl free radical- induced protein oxidation in rat brain","volume":"36","author":"Pocernich","year":"2000","journal-title":"Neurochem Int"},{"key":"10.1016\/j.mehy.2012.03.021_b0205","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF01958877","article-title":"Effects of cysteine and N-acetyl cysteine on GSH content of brain of adult rats","volume":"39","author":"Vina","year":"1983","journal-title":"Experientia"},{"key":"10.1016\/j.mehy.2012.03.021_b0210","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.freeradbiomed.2004.11.034","article-title":"Tissue-specific changes of mitochondrial functions in aged rats: effect of a long-term dietary treatment with N-acetylcysteine","volume":"38","author":"Coccoa","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.mehy.2012.03.021_b0215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3940(85)90229-0","article-title":"Partial protection from the dopaminergic neurotoxin Nmethyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse","volume":"60","author":"Perry","year":"1985","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2012.03.021_b0220","first-page":"48","article-title":"Attenuation of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine induced nigro-striatal toxicity in mice by N-acetyl cysteine","volume":"53","author":"Sharma","year":"2007","journal-title":"Cell Mol Biol"},{"key":"10.1016\/j.mehy.2012.03.021_b0225","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/exnr.1996.0136","article-title":"Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson\u2019s disease","volume":"141","author":"Offen","year":"1996","journal-title":"Exp Neurol"},{"key":"10.1016\/j.mehy.2012.03.021_b0230","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s11064-005-6867-7","article-title":"Effect of antioxidant diets on mitochondrial gene expression in rat brain during aging","volume":"30","author":"Nicoletti","year":"2005","journal-title":"Neurochem Res"},{"key":"10.1016\/j.mehy.2012.03.021_b0235","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.1523\/JNEUROSCI.18-20-08417.1998","article-title":"Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428","volume":"18","author":"McCann","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2012.03.021_b0240","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nm0696-699","article-title":"Striatal dopamine nerve terminal markers in human, chronic methamphetamine users","volume":"2","author":"Wilson","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2012.03.021_b0245","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1038\/sj.npp.1300512","article-title":"Protective effects of N-acetyl-l-cysteine on the reduction of dopamine transporters in the striatum of monkeys treated with methamphetamine","volume":"29","author":"Hashimoto","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2012.03.021_b0250","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nm0602-600","article-title":"Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease","volume":"8","author":"Xu","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2012.03.021_b0255","doi-asserted-by":"crossref","first-page":"e12333","DOI":"10.1371\/journal.pone.0012333","article-title":"Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in \u03b1-synuclein over-expressing mice","volume":"5","author":"Clark","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2012.03.021_b0260","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1523\/JNEUROSCI.15-04-02857.1995","article-title":"N-acetylcysteine (D-and L-stereoisomers) prevents apoptotic death of neuronal cells","volume":"15","author":"Ferrari","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2012.03.021_b0265","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1073\/pnas.91.16.7496","article-title":"N-acetyl-l-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro","volume":"91","author":"Mayer","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2012.03.021_b0270","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis","volume":"281","author":"Green","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.mehy.2012.03.021_b0275","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1523\/JNEUROSCI.14-07-04385.1994","article-title":"Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione","volume":"17","author":"Ratan","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2012.03.021_b0280","first-page":"1095","article-title":"Transforming growth factor beta 1-induced apoptosis in human ovarian carcinoma cells: protection by the antioxidant N-acetylcysteine and bcl-2","volume":"7","author":"Lafon","year":"1996","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.mehy.2012.03.021_b0285","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yexmp.2008.10.004","article-title":"Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice","volume":"86","author":"Aoki","year":"2009","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.mehy.2012.03.021_b0290","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/hmg\/ddp501","article-title":"Phosphorylation of parkin by Parkinson disease linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling","volume":"19","author":"Sha","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.mehy.2012.03.021_b0295","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1006\/excr.1995.1311","article-title":"Protective effects of N-acetylcysteine in tumor necrosis factor-alpha-induced apoptosis in U937 cells: the role of mitochondria","volume":"220","author":"Cossarizza","year":"1996","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.mehy.2012.03.021_b0300","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/MCB.15.5.2359","article-title":"Tumor necrosis factor-alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA","volume":"15","author":"Talley","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.mehy.2012.03.021_b0305","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/10715760802158430","article-title":"Quinone and oxyradical scavenging properties of N-acetylcysteine prevent dopamine mediated inhibition of Na+, K+-ATPase and mitochondrial electron transport chain activity in rat brain: implications in the neuroprotective therapy of Parkinson\u2019s disease","volume":"42","author":"Bagh","year":"2008","journal-title":"Free Radic Res"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987712001405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987712001405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T13:24:21Z","timestamp":1642166661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987712001405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0306987712001405"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2012.03.021","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}